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0&ctives. This study sought to investigate the role of nitric 
oxide, an endothelium-derived retaxing facto&, in flow-mediated 
vasodilatioo in buman epicardial coronary arteries. 
Bac&gmumf. Endotbelium-derived relaxing factors may be re- 
leased Ram the corunary artery eodothelium in response to 
increases in blood low. 
Met/mds. We studied the e&t of tbe nitric oxide synthesis 
iohiitor NC-monomethyl-L-arginine (L-NMMA) on the Row- 
q edfated vasodilation of epicardii coronary arteries in 12 pa- 
tients, using quantitative angiographic and Doppler flow velocity 
measurements. Adenosine at ItlO f&min was infused into the left 
anterior descending coronary artery to test the dilator response of 
the proximal artery to increases in blood flow. Acetylcholine at 3 
and 30 ccglmin was infused into the left coronary ostium to 
determine endothelium-dependent vasodilation of the proximal 
left anterior descending artery. Adenosine and acetylcboline were 
intased before and after tbe intracoronary infusion of L-NMMA 
(25 cumin for 5 min). 
Dilation of large conduit arteries has been shown to occur in 
response to in&eases in blood flow (1). This phenomenon has 
been observed in isolated, perfused canine coronary artery 
segments in situ (2) and during reactive hyperemia following 
brief coronary artery occlusion (3.4). Inoue et al. (5) have 
demonstrated that the flow-mediated dilation of epicardial 
coronary arteries in conscious dogs is attenuated by removal of 
the endothelium. They have suggested that the endothclium 
modifies smooth muscle tone, depending on the level of 
coronary blood flow. Rubanyi et al. (6) have found that, in 
perfused canine femoral arterial segments, increases in flow 
will triger the release of a vasodilating substance from endo- 
thelial cells that has characteristics similar to the endothelium- 
derived relaxing factor released by acetylcholine. 
Flow-mediated vasodiiation also has been demonstrated m 
human femoral, brachial and coronary arteries (7-9). Flow- 
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Resti. Infusion of L-NMMA caused a significant decrease in 
the baseline diameter of the proximal left anterior descending 
artery (from 2.90 + 0.14 to 2.74 + 0.13 mm [mean f SEMI, p 6 
0.01). Adeuosine increased coronary blood low before and after 
L-NMMA (+399.5 f 27.5% and +511.9 + 33.3%, respectively). 
Flow-mediated vasodilation was observed in the proximal left 
anterior descending artery before and after L-NMMA (+9.2 f 
1.5%, p c 0.01 and +8.6 f 2.194 p < 0.01, respectively). A dose of 
3 W(min of acetylcholine significantly dilated the proximal lefl 
anterior descending artery before L-NMMA (+7.6 -C l.O%, p C 
0.01). but acetylcboline-induced vasodilation was attenuated after 
L-NMMA (-1.8 + 1.0%). 
Conclusons. Our data suggest that nitric oxide modulates 
basal coronay artery tone but that medielors other than nitric 
oxide may be responsible for the flow-mediated vasodilation of 
human epicardial coronary arteries. 
(JAm Co.8 Cardial 19%;27:3044) 
mediated vasodilation is considered an important regulatory 
mechanism in the coronary circulation in humans. Indeed, 
physiologic stimuli that lead to an increase in coronary blood 
flow, including the use of papaverine or adenosine (W-12), 
bicycle exercise testing (13), cold pressor testing (14,15), and 
mental arithmetic (16), all have been shown to increase 
coronary artery diameter in patients witbout atherosclerosis or 
r&k factors for coronary artery disc.!sc. The vascular tone of 
intact coronary arteries in humans appears to be markedly 
modulated by changes in blood flow. However, an impaired 
response is seen in patients with atherosclerosis. The parallel 
response of coronary arteries to physiologic stimuli and to 
acetylcholine led investigators to the conclusion that endothe- 
hum-derived relaxing factor may be released from the endo- 
thelium in response to these stimuli. 
Endothelium-derived ielaxing factor was first demonstrated 
more than a decade ago by Furchgott and Zawadzki (17). The 
first proof that nitric oxide’was at least one of the relaxing 
factors resulted from studies by Palmer et al. (18). However, 
the role of nitric oxide in flow-mediated vasodilation is still 
u&own. The goal of the present study was to evaluate the 
role of nitric oxide in flow-mediated vasodilation in human 
epicardial coronary arteries. 
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W,N Figure I. Sequence of drug infusions and 
timing of coronary arteriography (CAG), 
which was performed just after the end 
of each infusion. L-NMMA = No- 
monomethyl-L-arginine: ING = nino- 
f f t f f f t glycerin. 
Methods 
Study patients. Twelve patients (three women, nine men; 
mean [ +SEM] age 57 ? 3 years, range 40 to 69) undergoing 
coronary angiography for the diagnosis of a chest pain syn- 
drome were studied. All patients had angiographically normal 
smooth epicardial coronary arteries, normal left ventricular 
function (contrast ventriculographic ejection fraction ~50%) 
and normal coronary flow reserve. Written informed consent 
was obtained from all patients before the diagnostic angio- 
gram, and all studies were approved by the Human Investiga- 
tion Ethical Committee of the University of Hiroshima. 
Study design. Antianginal therapy was discontinued 48 h 
before catheterization except for the unrestricted use of sub- 
lingual nitroglycerin, which was withheld 1 h before catheter- 
ization. Patients were brought to the catheterization laboratory 
in the fasting state after premeditation with hydroxyzine 
(25 mg intramuscularly) and promethazine hydrochloride 
(25 mg intramuscularly). 
Diagnostic right and left heart catheterization and coronary 
angiography were performed through a standard percutaneous 
femoral approach. .Atier vascular access had been obtained, 
10,000 U of heparin was given intravenously. A 7F guide 
catheter was introduced into the left main coronaty artery. A 
3F infusion catheter (Tracker 325, Target Therapeutics) was 
advanced through the guide catheter into the middle segment 
of the left anterior descending coronary artery. A 0.014-in. 
(0.36-mm) Doppler flow guide wire (FloWire, Curdiometrics) 
was then advanced through the infusion catheter into the 
middle segment of the artery. The tip of the Doppler flow 
guide wire was positioned distal to the end of the infusion 
catheter. The diameter of the central lumen of this infusion 
catheter is 0.024 in. (0.61 mm), so that we could infuse 
vasoactive agents through the infusion catheter in the presence 
of the O.OlCin. Doppler flow wire. 
Protocol. After completion of the diagnostic catheterixa- 
tion. the following interventions were performed (Fig. 1): After 
control conditions had been established, adenosine was infused 
at a dose of 100 Ccg/min into the distal left anterior descending 
coronary artery through the infusion catheter (1 ml/min for 
2 min). After reestablishment of control conditions, serial 
infusions of intracoronary acetylcholine (3 and 30 &min) 
were delivered into the :eft coronary ostium through the guide 
catheter (1 mllmin, each for 2 min). Then L-NMMA, at doses 
of 15 and 25 wol/min, was infused into the left coronary 
ostium through the guide catheter (1 ml/min, each for 5 min). 
Infusions of adenosine and acetylcholine were repeated after 
the infusion of L-NMMA (25 WoVmin). Finally, 200 Ccp/min 
of nitroglycerin was infused into the left coronary ostium. 
We waited 5 min after each infusion of adenosine and 
acetylcholine before beginning the next drug infusion. Coro- 
nary arteriography was performed under control conditions 
and just after the end of each infusion. Heart rate, arterial 
pressure, coronary blood flow velocity and electrocardiogram 
(ECG) were monitored continuously through each infusion. 
Each measurement also was recorded under steldy-state con- 
ditions. 
Quantitative coronary arteriogmphy. iloronzry cineangio- 
grams were recorded on 35-mm cinefilm i30 frames/s) using a 
Siemens cineangiographic system after selection of the view 
that allowed the best visualization of ihc left anterior descend- 
ing coronary artery. Nonionic contrast medium was injected 
into the left coronary artdry at the ra!e of 5 to 10 ml/s to a total 
of 7 to 10 ml. A power injector (Medrad) was used to optimize 
the quality and reproducibility of the opacification (19). An- 
giograms were obtained while the patients held their breath to 
avoid possible effects of respiration (20). A segment o: left 
anterior descending coronary artery that was free of side 
branches and was at least 5 mm proximal to the infusion 
catheter tip (the site of infusion of the adenosine) was selected 
for quantitative analysis (Fig. 2). This segment was exfrosed to 
changes in blood flow but was not directly exposed to adeno- 
sine. Serial infusions of acetylcholine were delivered through 
the guide catheter to this segment so that the same segment 
could be analyzed for the response to increasing blood flow 
and to acetylcholine. A segment of the artery at least 10 mm 
distal to the infusion catheter tip was selected for analysis of 
Fi 2. Coronary artery segments analyzed by qnantitalive angiog- 
raphy. A proximal segment of the left anterior descending (LAD) 
coronary artery (a segment proximal to the end of the infusion 
catheter) was analyzed for flow-mediated effects. A segment at the tip 
of the Doppler wire was analyzed to estimate the volume from fiow 
velocity meicsurements. A segment distal to the end of the mfusion 
catheter (Distal LAD) \I s analyzed for the direct e&et of adenosine. 
A proximal segment of the left ChmfleX eomnaty artery (~CX) was 
dnabyzed to exclude a second-pass effect of adenosine. 
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T&k 1. Hemodynamic Measurements - - 
ACh (F#min) 
- 
L-NMMA Baeline I Adcntrm! fiwline 2 3 30 TNG 
HR (beats/min) Before 64+3 65 ? 3 64tj 65 -c 3 6623 
After 6423 63 + 3 64 f : 63 c 3 62 + 3 68i-3’ 
BP (mm Hg) Before I(W) 2 3 IIUI t ‘ i loot 3 loo?3 97 t 3 
After 103 _+ 4 I02 + 4 I03 2 4 103 ? 3 1011 -c * 94 e 3’ 
RPP (katslmin . mm Hg) B&x 9,046 + 409 9.242 c 512 9.114 + 453 9.082 2 446 9.019 i 512 
Ahcr 9,440 f 47x 9.363 It 521 9,181 t- 531 9.406 + 559 9,220 -r 609 8.855 + 400 
‘p < 0.01 WS.US baseline control diameter (Baseline I) before N’-monomethyl-i,-arginine CL-NMMA). Data pwented are mean value + SEM. ACh = 
acetylcholine; Baseline 2 = repeat control diameter; BP = mean blood prewre; HR = heart rate; RPP = rawpressure product: TNG = nitroglycerin. 
the direct effects of adenosine. l’he proximal segment of the 
left circumflex coronary artery, whic:l was not exposed to 
adenosine or to increased blood flow, was analyzed to exciude 
a second-pass effect of the adenosine. 
Measurement of the lumen diameter of each arterial seg- 
ment was performed quantitatively with the aid of a computer- 
assisted coronary angiographic analysis system. The arterial 
segments under study were videodigitized at end-diastole and 
then stored in the cardiac image analysis system (Cardio 500, 
Kontron Instruments). Automated counter detection was per- 
fo.med by a geometric edge differentiation technique similar 
to the method described by Reiber et al. (21). The diameter of 
the segment of interest was measured, and the averaged value 
from triplicate measurements was used for later analysis. A 7F 
Judkins catheter was used to calibrate the arterial diameter in 
millimeters. The arterial diameter measurcmcats were done 
without knowledge of the clinical characteristics of the pa- 
tients. 
Measurements of coronary bled flow velocity and estima- 
tion of coronary blood flow. The Doppler guide wire with a 
12-MHz piezoelectric transducer at the tip (FloWire, Cardio- 
metrics) was used to measure the coronary artery blood flow 
velocity. The use of the Doppler flow guide wire for this 
purpose has been validated previously (22). Continuous-flow 
velocity profiles using the 12-MHz pulsed Doppler velocimeter 
(FloMap, Cardiometrics), along with simultaneous ECGs and 
aortic pressures, were displayed on the video monitor and 
recorded continuously on OS-in. VHS (12.7-mm) videotape. 
Changes in coronary blood flow evoked by the vasoactive 
agents were estimated from the product of the mean coronary 
blood flow velocity and the cross-sectional area 2 to 3 mm 
distal to the tip of the Doppler flow guide wire. This distance 
was selected because the Doppler transducer’ of this device has 
a range gate depth of 4.2 mm. 
Preparatinn of drugs. Acetylcholine (Daiichi Pharmaceu- 
tical Corp.) was dissolved in physiologic saline at a concentra- 
tion of 3 or 30 &ml. Acetylcholine was dissolved immediately 
before use because it is unstable in solution. Adenosine’(Sigma 
Chemical Co.) was dissolved in physiologic saline at a concen- 
tration of 100 &ml. The L-NIV&U (Sigma) was dissolved in 
physiologic saline at a concentration, of 15 or 25 ~mol/ml. 
Nitrogiycerin (Niionkayaku Corp.) was dissolved in physio- 
logic saline and infused at a concentration of 200 CLglmin. The 
infusion of each drug was performed with a;1 infusion pump 
(CFV X00, Nihonk&,l) at a rate of 1 ml/min. 
Statistical analysis. All data are expressed as mean 
value 2 SEM. Changes in lumen diameter are expressed as the 
percent change from the baseline control value. Two-way 
repeated-measures analysis of variance (ANOVA) was used to 
compare the effects of adenosine and acetylcholine on the 
systemic hemodynamic and coronary vascular responses before 
ar,d after the infusion of L-NMMA. One-way repeated- 
measures ANOVA was used to assess the effects of the 
L-NMMA infusions on the systemic hemodynamic and core- 
nary vascular responses. If the ANOVA showed a significant 
dilkrence between the means, the level of significance was 
determined by contrast analysis using the GLM procedure of 
the SAS statistical software. Paired data were compared by 
paired t tests. A value of p < 0.05 was considered significant. 
Results 
Hemodynamic variables. There were no significant 
changes in heart rate, mean arterial pressure or rate-pressure 
product during the infusions of adenosine or acetylcholine 
before or after L-NMMA (Table 1). Nitroglycerin increased 
heart rate (p < 0.01) and decreased mean arterial pressure 
(p < 0.01) compared with baseline values before L-NMMA. 
Effect of L-NMMA on baseline coronary blood Row and 
coronary diameter. Infusion of L-NMMA (1.5 pmol/min) pro- 
duced no significant change in coronary blood flow. Tue higher 
dose of L-NMMA (25 pmol’min) caused a decrease in baseline 
coronary blood flow, from 54.3 2 6 1 to 45.5 + 5.1 ml/min (p < 
0.01) (Table 2). 
The diameters of the proximal and distal left anterior 
descending coronary artery and the proximal left circumflex 
artery decreased significantly from baseline values before 
L-NMMA by 5.3 It 1.3%, 3.9 ‘2 1.2% and 7.2 t 1.6%, 
respectively (Fig. 3). 
Coronary blood flow changes during serial ,iafusions of 
adeoosioe and acetylcholme. Infusion of adenosine into the 
distal left anterior descending coronary artery produced signif- 
icant increases in coronary blood flow before and after 
L-NMMA (Table 2). However, the percent increase after 
L-NMMA was greater than that before L-FI~~MA (p < 0.01). 
Table 2. Changes in Coronary Blood Flow ___- 
Bcfwc L -NMMA AfiN / -NSIMJ. 
---- 
CBF (mlimin) change (‘;) CBF (ml InNI) (hnr.gc ( c) 
Serial infusions of acetylcholine caused significant increases in 
coronary blood flow before and after L-NMMA. 
Paired response of proximal leti anterior descending cor- 
onary artery to adenosiae and acetylcholine before and after 
bNMMA. Before L-NMMA, the proximal left anterior de- 
scending coronary artery dilated in response to increases in 
blood flow during the infusion of adenosine (9.2 I? l.S%, p < 
0.01) (Fig. 4A). Acetylcholine infusion (3 &min) also caused 
a significant dilation in the proximal segment of the artery 
(7.0 2 1.0% p < 0.01). 
Flow-mediated dilation during adenosine infusion after 
L-NMMA was similar to that before L-NMMA. In contrast, 
Figure 3. Effect of intracoronary infusion of NC’-monomethyk- 
ar$nine (L-NMMA) (15 and 25 pmollmin) and nitroglycerin (MG) 
(26~ &min) on baseline coronary diameter of (A) proximal left 
anterior descending coronary artery (LAD), (B) distal left anterior 
desctnding coronary artery and (C) proximal left circumflex coronary 
artery (LCx). C = baseline (before L-NMMA). ‘p < 0.01 versus 
baseline diameters before L-NMMA. Data shown are mean value 5 
SEM. 
after 1 -SMM,A the -‘?roca;,’ diameter respnse to s&al 
infusions of acetylcholine was Ggnificantly di%erent from that 
before I.-NMMA. Acetylcholinc infusion (3 pg/min) did not 
produce significant dilation of the proximal segment of the 
left anterior descending coronary artery (p = 0.3445). Thus, 
L-NMMA attenuated acetylcholine-induced endothelium- 
dependent dilation but had no effect on flow-mediakd base- 
dilation. 
Direct drug-induced dilation in distal left anterior descend- 
ing cwo~sr~ artery and proximal left circumflex artery. The 
segment of left anterior descending coronary artery distal to 
tile tip of the infusion catheter dilated in response to adenosine 
by 20.5 x 3.6% (p < @.Ol) before L-NMMA and by 21.0 t 
Figure 4. Sequential coroilary wsomotor response of (A) proximal left 
anterior descending coronary artery (LAD). (B) distal LAD and tC) 
proximal left circumf!ex coronary artcry (LCx) to serial infusions of 
adcnosine (adcn) (100 &minj and acetylcholine (AC?) (3 and 
30 ppimin) before and after N”-monomethyk-arginine (I-NMMA). 
Cl = baseline control diameter; C2 = repeat control diameter. “p c: 
0.05, **p < 0.01 versus haseline control diameter. Data shown are 
mean value -C SEM. 
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3.5% (p < 0.01) after L-NMMA (Fig. 4B). There was no 
significant dilation of the proximai segment of the leit circum- 
flex artery during adenosine infusion before or after I.-NMMA 
(Fig. 4C), thus excluding a significant direct second-pass effect 
of adenosine on the protimai segment of the left anterior 
descending coronary artery. 
Acetyichoiine infusion (7 Ccp/min) caused significant diia- 
tion in the distal segment of left anterior descending coronary 
artery and the proximal segment of left circumflex artery 
before L-NMMA. However, this endotheiium-dependent, 
acetyichoiine-induced dilation was attenuated after infu- 
sions of L-NMMA. The higher dose acetyichoiine infusion 
(30 &min) produced no significant changes in coronav artery 
diameter before L-NMMA but caused decreases in the diam- 
eter of the distal left anterior descending coronary artery and 
the proximal left circumflex artery after L-NMMA. 
Response to endothelium-independent vasodilator nitro- 
glycerin. Nitroglycerin infusion induced significant dilation of 
the proximal (14.6 2 1.8%) and distal left anterior descending 
coronary artery (21.7 t 3.3%) and the proximal left circumflex 
artery (18.6 2 2.6%) (Fig. 3). 
Discussion 
Tlie major ficdings of the present study are that L-NMMA, 
a specific inhibitor of nitric oxide synthesis, caused a decrease 
in baseline coronary diameter and attenuated acetyichoiine- 
induced endothelium-dependent coronary dilation. However, 
L-NMMA had no effect on flow-mediated coronary dilation. 
These findings suggest that there is basal release of nitric oxide 
in human epicardial coronary arteries but that nitric oxide does 
not regulate flow-mediated vasodilation. Flow-mediated diia- 
tioo may be mediated by endotheiium-derived relaxing factors 
other than nitric oxide. 
Effect of inhibition of nitric oxide synthesis on fbnv- 
mediated vasodilation: comparison with other stodiis. To our 
knowledge, this is the first study to report the effects of a nitric 
oxide synthesis inhibitor on flow-mediated vasodilation in 
human epicardial coronary arteries. A limited number of in 
vivo studies have examined the effects of the inhibition of nitric 
oxide synthesis on flow-mediated epicardial coronary vasodi- 
lation in animals. Canty and Schwa z (23) reported that it 
conscious dogs, inhibiting nitric oxide production by N-nitro- 
L-arginine methyl ester (L-NAME) had no effect on epicardial 
coronary dilation in response to increases in blood flow 
induced by adenosine at a constant heart rate but that the 
epicardial artery dilation in response to increases in blood flow 
induced by pacing was attenuated by L-NAME. Recently, 
Smith et al. (24) reported that L-NAME fails to attenuate 
flow-mediated dilation in canine epicardial coronary arteries. 
Our results with L-NMMA are similar to the findings of Canty 
and Schwartz (23) and Smith et al. (24) and indicate that 
flow-mediated vasodilation is not dependent on nitric oxide 
production in epicardial coronary arteries. 
In contrast to the results of our study, Kuo et al. (25) 
showed that flow-mediated vasodilation in isolated subepicar- 
JAC’C Vol. 27. No. 2 
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dial porcine arterioles (-80-pm rest diameterj is abolished by 
inhibiting nitric oxide production with I.-NMMA. A number of 
studies have demonstrated diffcrentiai responses of coronary 
conduit and resistance vessels to pharmacologic stimuli, such 
as thrombin, vasopressin and nitrate (26,27). The mechaniims 
responsible for flow-mediated vasodiiation in each class of 
vessel may be different, and nitric oxide-dependent mecha- 
nisms may predominate in coronary resistance vessels. 
Lieberman et al. (28) reported that L-NMMA reduces 
flow-mediated vasodiiation and acetyichoiine-induced vasodi- 
laGon iu human brachiai arteries. They suggested that flow- 
mediated dildtion of human brachiai artery is partially medi- 
ated by nitric oxide. However, endotheiium-dependent 
vasodiiator mechanisms may differ among different vascular 
beds in humans (29). Therefore, vasodiiator mechanisms in- 
duced by increasing flow may differ between the coronary and 
brachiai artery beds. 
Mechanisms of flow-mediated vasodilation in buman epi- 
cardial coronary arteries. Although our results indicate that 
nitric oxide production is not required for the flow-mediated 
vasodiiation of epicardial coronary arteries, we did not identify 
the other mediators that may be responsible for these re- 
sponses. In previous studies, it has been demonstrated that 
flow-mediated effects are abolished by denuding the endothe- 
iium in vitro (30) and in V;VO (5). Although prostacyciins or 
other prostanoids may affect basal tone, previous studies have 
shown that they are unlikely to be mediators of flow-mediated 
vasodiiation (4,6,31). Several investigators have reported that a 
soluble hyperpoiarizing factor is released in response to a 
variety of endotheiium-dependent agonists (32,33). Although 
this factor has not been identified, it could explain the fiow- 
induced dilation observed in the present study. Another pos- 
sibility is that the flow-mediated vasodiiation of epicardial 
coronary arteries is mediated by direct hyperpoiarization of the 
endotheiial ceil by Iuminai shear stress (34). It has been 
proposed that activation of a hyperpolarizing potassium cur- 
rent within the endotheiium may produce dilation in response 
to increases in flow (35). This mechanism has been demon- 
strated in cultured endotheiiai cells, but its impcrtance in vivo 
remains to be defined. 
Basal release of nitric oxide. Severni studies support the 
concept that the intact coronary vascular bed is maintained 
under a constant dilating tone by basal, agonist-independent 
release of endotheiium-derived relaxing factor (36-38). Lefroy 
et al. (39) demonstrated that there ‘is basal release of nitric 
oxide in human epicardial coronary arteries and resistance 
vessels. In our study, L-NMMA caused decreases in the basal 
diameter of the proximal and distal epicardial coronary arteries 
and decreases in basal coronary blood flow. This finding suggests 
that there is basal release of nitric oxide in the proximal and distal 
epicardial arteries and resistance vessels in humans. 
Stody limitations. We used 15 and 25 pol/min infusions 
of L-NMMA for 5 min. Lefroy et al. (39) reported that 4, 10 
and 25 FmoUmin infusions of L-NMMA for 5 min abolish 
acetyichoiine-induced dilation of human epicardial coronary 
arteries. We also observed that endothelium-dependent vaso- 
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dilation induced by a 3 @min infusion of acetylcholine was 
attenuated after I.-NMMA. Thus, at the dose we used, 
L-NMMA-attenuated epicardial coronary dilation caused 
by agonist-induced nitric oxide production. In contrast, 
acetylcholine-induced increases in coronary blood flow were 
not attenuated after L-NMMA infusions. Recent studies in 
humans (3”) and in dogs (40) have shown that acetylcholine- 
induced dilhtion of resistance vessels is not abolished by 
. . f nitric 0x1~~ 5 ,’ ,sis inhibitors. This finding is in keeping 
with the rc. f: ri our study, in which L-NMMA did not 
attenuate abctyrcholine-induced increases in blood flop. 
Although previous studies have suggested that the coronary 
artery flow-&meter relation is linear (4,10), the effects of 
inhibiting nitric oxide production on this relation are unknown. 
High levels of Ilo?. may ovexome the biockade of nitric oxide 
production produced hy L-NMMA. Studies of flow-diameter 
relation pelfnrmed over a wide range of flows will be required 
to address this n,zstion. 
Finally, L-NMMA caused a decrease in the basal coronary 
artery diameter, indicating that there is a basal release of nitric 
oxide in humar epicardial coronary arteries. However, L- 
NMMA caused a significant decrease in basal coronary artery 
blood flow. This finding suggests that the decrease in basal 
diameter after L-NMMA may be caused by reductions in shear 
stress and not by the inhibition of the basal release of nitric 
oxide in the arterial beds. Smith et al. (24) have demonstrated 
that in conscious dogs, inhibiting nitric oxide production with 
L-NAME reduces coronary artery diameter under rest condi- 
tions, although coronary blood flow is not changed. It was 
impossible in our study in patients to keep basal coronary 
blood flow at a constant rate both before and After I.-NMMA. 
Conclusions. Inhibition of nitric gxiti.: synthesis by the 
intracoronary infusion of L-NMMA decreased the basal epi- 
cardial corollary artery diameter but did not attenuate Row- 
mediated vasodilation. The* findings indicate that nitric oxide 
modulates basal tone but that mediators other than nitric oxide 
may be responsible for the flow-mediated vasodilation of 
human epicardial coronary arteries. 
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